438613-29-7

Usage

Uses

Used in Pharmaceutical Industry:
6-BROMO-3-CHLORO-BENZO[B]THIOPHENE-2-CARBOXYLIC ACID is used as a key intermediate in the development of new drugs. Its unique structure and functional groups allow for the creation of diverse chemical entities with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 6-BROMO-3-CHLORO-BENZO[B]THIOPHENE-2-CARBOXYLIC ACID serves as a precursor in the synthesis of pesticides and herbicides. Its chemical properties make it suitable for the design of effective and targeted agrochemicals.
Used as an Intermediate in Organic Synthesis:
6-BROMO-3-CHLORO-BENZO[B]THIOPHENE-2-CARBOXYLIC ACID is utilized as an intermediate in the production of other organic compounds. Its reactivity and structural features facilitate its use in various chemical reactions, contributing to the synthesis of a wide range of organic molecules for different applications.

Upstream product

• 227803-28-3 ethyl 6-bromo-3-chlorobenzo[b]thiophene-2-carboxylate 
• 3943-97-3 methyl 4-hydroxycinnamate 
• 1200-07-3 trans-4-bromocinnamic acid 
• 19075-58-2 6-bromo-1-benzothiophene-2-carboxylic acid 

Relevant academic research and scientific papers

Synthesis Development of the Selective Estrogen Receptor Degrader (SERD) LSZ102 from a Suzuki Coupling to a C-H Activation Strategy

The development of the synthetic process to the selective estrogen receptor degrader (SERD) drug candidate LSZ102 from the medicinal chemistry synthesis to the streamlined large-scale manufacturing route is described. The synthesis of LSZ102 could be sign

AMINOISOXAZOLINE COMPOUNDS AS AGONISTS OF ALPHA7-NICOTINIC ACETYLCHOLINE RECEPTORS

The present invention relates to novel aminoisoxazoline compounds, and pharmaceutical compositions of the same, that are suitable as agonists or partial agonists of α7-nAChR, and methods of preparing these compounds and compositions, and the use of these compounds and compositions in methods of maintaining, treating and/or improving cognitive function. In particular, methods of administering the compound or composition to a patient in need thereof, for example a patient with a cognitive deficiency and/or a desire to enhance cognitive function, that may derive a benefit therefrom.